Biosensors,
Journal Year:
2023,
Volume and Issue:
13(11), P. 970 - 970
Published: Nov. 6, 2023
In
this
study,
an
impedance
biosensor
capable
of
real-time
monitoring
the
growth
and
drug
reactions
using
NIH/3T3
cells
was
fabricated
through
a
semiconductor
process.
With
biosensor,
cell
reaction
states
are
monitored
in
real-time,
showing
validness
developed
biosensor.
By
we
have
investigated
capacitance
contribution
existing
on
electrodes
between
electrodes.
To
compare
value
contributions
electrodes,
wide-
narrow-gap
electrode
patterns
manufactured
with
3.7
0.3
mm
gap
spacings,
respectively.
From
detailed
analysis,
estimated
around
less
than
20
percent
compared
to
other
words,
minimized
area
maximized
spacing
is
promising
design
guide
for
accurate
measurements.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
153, P. 113538 - 113538
Published: Aug. 12, 2022
The
World
Health
Organizations
declaration
of
the
COVID-19
pandemic
was
a
milestone
for
scientific
community.
high
transmission
rate
and
huge
number
deaths,
along
with
lack
knowledge
about
virus
evolution
disease,
stimulated
relentless
search
diagnostic
tests,
treatments,
vaccines.
main
challenges
were
differential
diagnosis
development
specific,
rapid,
sensitive
tests
that
could
reach
all
people.
RT-PCR
remains
gold
standard
diagnosing
COVID-19.
However,
new
methods,
such
as
other
molecular
techniques
immunoassays
emerged.
Also,
need
accessible
quick
results
boosted
point
care
(POCT)
are
fast,
automated,
precision
accuracy.
This
assay
reduces
dependence
on
laboratory
conditions
mass
testing
population,
dispersing
pressure
regarding
screening
detection.
review
summarizes
advances
in
field
since
started,
emphasizing
various
detecting
We
reviewed
existing
well
POCT
under
development,
starting
detection,
but
also
exploring
nucleic
acid
techniques,
digital
PCR,
loop-mediated
isothermal
amplification-based
(RT-LAMP),
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR),
next-generation
sequencing
(NGS),
immunoassay
nanoparticle-based
biosensors,
developed
portable
instruments
rapid
Discover Chemistry.,
Journal Year:
2024,
Volume and Issue:
1(1)
Published: Oct. 25, 2024
Biosensor
is
a
revolutionary
diagnostic
tool
that
harnesses
the
synergy
of
biology
and
technology
to
detect
quantify
target
analytes,
enabling
real-time
monitoring,
early
disease
diagnosis,
innovative
applications.
Recent
advancements
in
biocompatible
materials
have
brought
about
significant
transformation
development
biosensors.
These
tools
are
essential
modern
healthcare
diagnostics
environmental
monitoring.
This
article
highlights
crucial
role
enhancing
performance
safety
next-generation
Innovative
substances
such
as
graphene,
hydrogels,
nanocomposites
been
developed,
significantly
improving
sensor
functionality
compatibility
with
biological
systems.
However,
challenges
associated
deploying
these
include
scalability,
manufacturing
processes,
long-term
stability.
emphasizes
transformative
potential
advancing
biosensor
technologies
expanding
their
applications
across
various
fields.
Detailed
analysis
illustrates
how
contribute
evolution
biosensors,
offering
more
precise,
reliable,
accessible
diagnostics.
Biosensors,
Journal Year:
2022,
Volume and Issue:
12(10), P. 898 - 898
Published: Oct. 20, 2022
The
COVID-19
pandemic
has
severely
impacted
normal
human
life
worldwide.
Due
to
its
rapid
community
spread
and
high
mortality
statistics,
the
development
of
prompt
diagnostic
tests
for
a
massive
number
samples
is
essential.
Currently
used
traditional
methods
are
often
expensive,
time-consuming,
laboratory-based,
unable
handle
large
specimens
in
resource-limited
settings.
Because
contagiousness,
efficient
identification
SARS-CoV-2
carriers
crucial.
As
advantages
adopting
biosensors
diagnosis
increase,
this
narrative
review
summarizes
recent
advances
respective
reasons
consider
applying
biosensors.
Biosensors
most
sensitive,
specific,
rapid,
user-friendly
tools
having
potential
deliver
point-of-care
diagnostics
beyond
standards.
This
provides
brief
introduction
conventional
their
disadvantages.
It
also
discusses
pathogenesis
COVID-19,
biomarkers,
using
biosensor
technology.
current
advancements
biosensing
technologies,
from
academic
research
commercial
achievements,
have
been
emphasized
publications.
We
covered
wide
range
topics,
including
biomarker
detection,
viral
genomes,
proteins,
immune
responses
infection,
other
proinflammatory
biomolecules.
Major
challenges
prospects
future
application
settings
highlighted.
Biosensors,
Journal Year:
2022,
Volume and Issue:
12(8), P. 637 - 637
Published: Aug. 13, 2022
The
novel
coronavirus
appeared
to
be
a
milder
infection
initially,
but
the
unexpected
outbreak
of
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
commonly
called
COVID-19,
was
transmitted
all
over
world
in
late
2019
and
caused
pandemic.
Human
health
has
been
disastrously
affected
by
SARS-CoV-2,
which
is
still
evolving
causing
more
serious
concerns,
leading
innumerable
loss
lives.
Thus,
this
review
provides
an
outline
traditional
tools
diagnose
role
emerging
nanomaterials
with
unique
properties
for
fabricating
biosensor
devices
SARS-CoV-2.
Smart
intelligent
nanomaterial-enabled
biosensors
(nanobiosensors)
have
already
proven
their
utility
diagnosis
several
viral
infections,
as
various
detection
strategies
based
on
nanobiosensor
are
present,
other
methods
also
being
investigated
researchers
determination
SARS-CoV-2
disease;
however,
considerably
undetermined
yet
explored.
Hence,
highlights
determination.
Further,
it
emphasizes
future
outlook
nanobiosensing
technologies
diagnosis.
BMJ Open,
Journal Year:
2025,
Volume and Issue:
15(4), P. e089598 - e089598
Published: April 1, 2025
Background
Infectious
agents
such
as
SARS-CoV-2
require
strategies
to
contain
outbreaks,
particularly
in
hospitals
where
the
spread
of
infection
is
most
likely.
Biometric
monitoring
heart
rate,
temperature,
oxygen
saturations
and
sleep
might
provide
important
early
warning
signs
for
SARS-CoV-2.
This
study
aimed
determine
whether
a
smart
medical
device
(E4
wristband)
pulse
oximeter
used
continuously
measure
skin
temperature
saturation
would
predict
onset
infection.
Methods
A
single-centre,
prospective
observational
cohort
30
healthcare
workers
(HCWs)
working
areas
at
high
risk
exposure
were
enrolled.
HCWs
tested
using
RT-qPCR
daily
self-administered
swabs
days.
Each
participant
was
asked
wear
an
E4
wristband
changes
their
throughout
study.
Results
Nine
(30%)
(median
(range)
age
39
(27–57)
years)
positive
COVID-19.
No
significant
differences
found
pre-infection
post-infection
variations
rate
(p=0.31)
or
(p=0.44).
Seven
nine
subjects
reported
symptoms
some
point
during
period:
unusual
fatigue
(40%),
headache
(33%)
runny
nose
(22%)
frequent.
Analysis
trends
observations
demonstrated
fluctuations
biometric
parameters.
Conclusion
These
results
suggest
that
wearable
technology
be
useful
documenting
exposed
HCWs.
Trial
registration
number
NCT04363489
.
